Form 4 for RMD ResMed|
Accepted 2024-02-23 00:00:00 ET · period of report 2023-05-03 · accession 0001127602-24-006731 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-23 | 2023-05-03+ | RMD | FARRELL PETER C | Dir | S - Sale | $211.84 | -23.5K | 166.9K | -12% | -$4.99M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2024-02-22 | S | D | 10,935 | $182.66 | 157,404 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $182.41 - $183.07. The price reported above reflects the weighted average sale price. |
| 2 | Common | ResMed Common Stock | 2023-05-03 | S | D | 12,600 | $237.17 | 166,896 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $236.40 - $237.94. The price reported above reflects the weighted average sale price. |